CLINICAL_TRIALS ClinicalTrials.gov record update

Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® Capsules Compared to Placebo After an Initial 12 Week Treatment Regimen With Oracea® and MetroGel® 1% in Adults With Rosacea

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01426269
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:33.220569+00:00
Published At: 2014-08-04T00:00:00+00:00
Record Updated At: 2022-08-01
Results Posted At: 2014-08-04
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Rosacea"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-08-01"
protocolSection.identificationModule.nctId: "NCT01426269"
protocolSection.identificationModule.officialTitle: "Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea\u00ae Capsules Compared to Placebo After an Initial 12 Week Treatment Regimen With Oracea\u00ae and MetroGel\u00ae 1% in Adults With Rosacea"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2014-08-04"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.